We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.

Welcome to Pump.fun!
Pump lets anyone create coins, giving everyone equal access to buy and sell from the start. Prices can move quickly, so trade carefully.
By clicking this button, you agree to the Terms and Conditions, Privacy Policy, and certify that you are over 18 years old.
| $170.76% | |
| $160.73% | |
| $60.30% | |
| $10.07% | |
| $0.250.01% | |
| $0.220.01% | |
| $0.170.01% | |
| $0.120.01% | |
| $0.120.01% | |
| $0.090.00% |
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.